Oláh J - Search Results

1

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma.

Sarnaik AA, Hamid O, Khushalani NI, Lewis KD, Medina T, Kluger HM, Thomas SS, Domingo-Musibay E, Pavlick AC, Whitman ED, Martin-Algarra S, Corrie P, Curti BD, Oláh J, Lutzky J, Weber JS, Larkin JMG, Shi W, Takamura T, Jagasia M, Qin H, Wu X, Chartier C, Graf Finckenstein F, Fardis M, Kirkwood JM, Chesney JA. Sarnaik AA, et al. Among authors: olah j. J Clin Oncol. 2021 Aug 20;39(24):2656-2666. doi: 10.1200/JCO.21.00612. Epub 2021 May 12. J Clin Oncol. 2021. PMID: 33979178 Free PMC article.

2

Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy.

Balatoni T, Mohos A, Papp E, Sebestyén T, Liszkay G, Oláh J, Varga A, Lengyel Z, Emri G, Gaudi I, Ladányi A. Balatoni T, et al. Among authors: olah j. Cancer Immunol Immunother. 2018 Jan;67(1):141-151. doi: 10.1007/s00262-017-2072-1. Epub 2017 Oct 7. Cancer Immunol Immunother. 2018. PMID: 28988380 Free PMC article.

3

Electrochemotherapy of cutaneous metastases of melanoma--a case series study and systematic review of the evidence.

Kis E, Oláh J, Ócsai H, Baltas E, Gyulai R, Kemény L, Horvath AR. Kis E, et al. Among authors: olah j. Dermatol Surg. 2011 Jun;37(6):816-24. doi: 10.1111/j.1524-4725.2011.01951..x. Dermatol Surg. 2011. PMID: 21605245 Review.

4

[Advances in immunotherapy for metastatic melanoma].

Oláh J. Oláh J. Magy Onkol. 2017 Jun 6;61(2):132-136. Epub 2017 May 10. Magy Onkol. 2017. PMID: 28585614 Free article. Review. Hungarian.

5

Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma.

Ladányi A, Papp E, Mohos A, Balatoni T, Liszkay G, Oláh J, Varga A, Lengyel Z, Emri G, Ferrone S. Ladányi A, et al. Among authors: olah j. J Immunother Cancer. 2020 Jun;8(1):e000209. doi: 10.1136/jitc-2019-000209. J Immunother Cancer. 2020. PMID: 32554608 Free PMC article.

6

[How to choose the optimal therapy? New issues in the treatment of metastatic melanoma].

Oláh J, Gyulai R. Oláh J, et al. Magy Onkol. 2016 Mar 2;60(1):17-21. Epub 2016 Jan 26. Magy Onkol. 2016. PMID: 26934346 Free article. Review. Hungarian.

7

[mmunotherapy of cutaneous melanoma - update 2022].

Oláh J. Oláh J. Magy Onkol. 2022 Jun 20;66(2):119-124. Epub 2022 Jun 6. Magy Onkol. 2022. PMID: 35724388 Free article. Review. Hungarian.

8

Cutaneous dysplastic naevi in uveal melanoma patients: markers for prognosis?

Tóth-Molnár E, Hammer H, Oláh J. Tóth-Molnár E, et al. Among authors: olah j. Melanoma Res. 2000 Feb;10(1):36-9. Melanoma Res. 2000. PMID: 10711638

9

Dysplastic nevi are a risk factor for uveal melanoma.

Hammer H, Oláh J, Tóth-Molnár E. Hammer H, et al. Among authors: olah j. Eur J Ophthalmol. 1996 Oct-Dec;6(4):472-4. doi: 10.1177/112067219600600423. Eur J Ophthalmol. 1996. PMID: 8997595

10

Melanoma and melanocytic nevi in decorative tattoos: three case reports.

Varga E, Korom I, Varga J, Kohán J, Kemény L, Oláh J. Varga E, et al. Among authors: olah j. J Cutan Pathol. 2011 Dec;38(12):994-8. doi: 10.1111/j.1600-0560.2011.01788.x. Epub 2011 Aug 23. J Cutan Pathol. 2011. PMID: 21883372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page